JP2006528643A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528643A5
JP2006528643A5 JP2006521295A JP2006521295A JP2006528643A5 JP 2006528643 A5 JP2006528643 A5 JP 2006528643A5 JP 2006521295 A JP2006521295 A JP 2006521295A JP 2006521295 A JP2006521295 A JP 2006521295A JP 2006528643 A5 JP2006528643 A5 JP 2006528643A5
Authority
JP
Japan
Prior art keywords
halo
membered
alkyl
alkenyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521295A
Other languages
English (en)
Japanese (ja)
Other versions
JP4521777B2 (ja
JP2006528643A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/023914 external-priority patent/WO2005009988A1/en
Publication of JP2006528643A publication Critical patent/JP2006528643A/ja
Publication of JP2006528643A5 publication Critical patent/JP2006528643A5/ja
Application granted granted Critical
Publication of JP4521777B2 publication Critical patent/JP4521777B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521295A 2003-07-24 2004-07-23 疼痛治療または予防に有用な４−ヘテロアリール−テトラヒドロピペリジル化合物 Expired - Fee Related JP4521777B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48951603P 2003-07-24 2003-07-24
PCT/US2004/023914 WO2005009988A1 (en) 2003-07-24 2004-07-23 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain

Publications (3)

Publication Number Publication Date
JP2006528643A JP2006528643A (ja) 2006-12-21
JP2006528643A5 true JP2006528643A5 (enExample) 2008-03-06
JP4521777B2 JP4521777B2 (ja) 2010-08-11

Family

ID=34102893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521295A Expired - Fee Related JP4521777B2 (ja) 2003-07-24 2004-07-23 疼痛治療または予防に有用な４−ヘテロアリール−テトラヒドロピペリジル化合物

Country Status (28)

Country Link
US (4) US7776861B2 (enExample)
EP (2) EP2080757A1 (enExample)
JP (1) JP4521777B2 (enExample)
KR (2) KR100896499B1 (enExample)
CN (3) CN102442995A (enExample)
AT (2) ATE431822T1 (enExample)
AU (1) AU2004259358B2 (enExample)
BR (1) BRPI0412248B1 (enExample)
CA (1) CA2533515C (enExample)
CY (1) CY1109318T1 (enExample)
DE (2) DE602004017316D1 (enExample)
DK (2) DK1648879T3 (enExample)
EA (1) EA009480B1 (enExample)
EG (1) EG25185A (enExample)
ES (1) ES2327684T3 (enExample)
GE (1) GEP20094675B (enExample)
HR (1) HRP20090442T1 (enExample)
IL (2) IL173344A (enExample)
IS (1) IS2593B (enExample)
MA (1) MA27948A1 (enExample)
MX (1) MXPA06000940A (enExample)
NO (1) NO331675B1 (enExample)
NZ (1) NZ544009A (enExample)
PT (1) PT1867644E (enExample)
SI (1) SI1867644T1 (enExample)
UA (1) UA83855C2 (enExample)
WO (1) WO2005009988A1 (enExample)
ZA (1) ZA200509997B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE452637T1 (de) 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält
US7157462B2 (en) * 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
AR044688A1 (es) 2003-06-12 2005-09-21 Euro Celtique Sa Agentes terapeuticos utiles para el tratamiento del dolor
CA2533515C (en) * 2003-07-24 2011-05-31 Euro-Celtique S.A. Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
PL1867644T3 (pl) 2003-07-24 2009-10-30 Euro Celtique Sa Związki heteroarylo-tetrahydropiperydylowe przydatne w leczeniu lub zapobieganiu bólu
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
US8315162B2 (en) 2006-08-24 2012-11-20 Research In Motion Limited System and method for determining that a maximum number of IP sessions have been established
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
AU2011226773C1 (en) * 2007-04-27 2012-07-26 Purdue Pharma L.P. TRPV1 antagonists and uses thereof
EP2479173A1 (en) 2007-04-27 2012-07-25 Purdue Pharma LP Therapeutic agents useful for treating pain
CN101932570B (zh) 2007-04-27 2014-11-26 普渡制药公司 Trpv1拮抗剂以及其用途
US8759362B2 (en) * 2008-10-24 2014-06-24 Purdue Pharma L.P. Bicycloheteroaryl compounds and their use as TRPV1 ligands
US8703962B2 (en) * 2008-10-24 2014-04-22 Purdue Pharma L.P. Monocyclic compounds and their use as TRPV1 ligands
EP2585446A4 (en) * 2010-06-22 2013-12-25 Shionogi & Co COMPOUNDS HAVING ANTAGONIST ACTIVITY OF TRPV1 AND USES THEREOF
AU2011291034A1 (en) * 2010-08-20 2013-03-14 Grünenthal GmbH Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
AR084457A1 (es) 2010-12-22 2013-05-15 Lundbeck & Co As H Derivados de biciclo[3,2,1]octilamida
WO2012158844A1 (en) 2011-05-17 2012-11-22 Shionogi & Co., Ltd. Heterocyclic compounds
EP3173411B1 (en) 2011-06-22 2018-05-09 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
WO2013021276A1 (en) 2011-08-10 2013-02-14 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
US8924211B2 (en) * 2012-07-09 2014-12-30 Nuance Communications, Inc. Detecting potential significant errors in speech recognition results
US9064492B2 (en) 2012-07-09 2015-06-23 Nuance Communications, Inc. Detecting potential significant errors in speech recognition results
WO2015044759A1 (en) 2013-09-24 2015-04-02 Purdue Pharma L.P. Treatment of burn pain by trpv1 modulators
WO2015148271A1 (en) * 2014-03-26 2015-10-01 Vivid Pharma, Inc. Compositions for treating or preventing alcohol-induced symptoms
US10668041B2 (en) 2014-12-08 2020-06-02 Societe Des Produits Nestle Sa Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
NZ730880A (en) * 2014-12-08 2022-07-01 Nestle Sa Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
PT3319959T (pt) 2015-07-06 2021-12-06 Alkermes Inc Inibidores hetero-halo de histona desacetilase
US10421756B2 (en) 2015-07-06 2019-09-24 Rodin Therapeutics, Inc. Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase
US9943513B1 (en) 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US10335405B1 (en) 2016-05-04 2019-07-02 Patheon Softgels, Inc. Non-burst releasing pharmaceutical composition
WO2017202376A1 (zh) * 2016-05-26 2017-11-30 南京明德新药研发股份有限公司 磺酰胺衍生物
EP3490560B1 (en) 2016-07-29 2025-01-22 Janssen Pharmaceutica, N.V. Niraparib for use in a method of treating prostate cancer
KR102526032B1 (ko) 2017-01-11 2023-04-25 로딘 테라퓨틱스, 인크. 히스톤 데아세틸라제의 바이시클릭 억제제
US10335375B2 (en) 2017-05-30 2019-07-02 Patheon Softgels, Inc. Anti-overingestion abuse deterrent compositions
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
DK3664802T3 (en) 2017-08-07 2022-05-30 Alkermes Inc Bicyclic inhibitors of histone deacetylase
DE102022104759A1 (de) 2022-02-28 2023-08-31 SCi Kontor GmbH Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen
JPWO2024095962A1 (enExample) 2022-10-31 2024-05-10

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE757436A (fr) * 1969-10-27 1971-03-16 Robins Co Inc A H 1-carbamoyl-4-phenyl-piperidines et -tetrahydropyridines, leur procede de preparation et leurs applications comme anticonvulsivants et relaxants musculaires
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DE3440141A1 (de) 1984-11-02 1986-05-07 Heiner Dipl.-Chem. Dr. 8000 München Eckert Verwendung von kohlensaeure-bis-trichlormethylester als proreagens fuer phosgen
JPH0680054B2 (ja) 1985-06-19 1994-10-12 吉富製薬株式会社 ピペリジン誘導体
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US4797419A (en) * 1986-11-03 1989-01-10 Warner-Lambert Company Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
US5198459A (en) * 1987-07-11 1993-03-30 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5506191A (en) * 1987-11-02 1996-04-09 Sandoz Ltd. Heterocyclic hydrazines and hydrazones
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5075341A (en) * 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US6204284B1 (en) * 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5232934A (en) * 1992-07-17 1993-08-03 Warner-Lambert Co. Method for the treatment of psychomotor stimulant addiction
DE4234295A1 (de) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5556837A (en) * 1994-08-01 1996-09-17 Regeneron Pharmaceuticals Inc. Methods for treating addictive disorders
US5762925A (en) * 1994-11-03 1998-06-09 Sagen; Jacqueline Preventing opiate tolerance by cellular implantation
CA2224517A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
NZ315677A (en) * 1995-09-07 2000-02-28 F 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
FR2740134B1 (fr) 1995-10-18 1998-01-09 Pf Medicament Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
FR2744448B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
DE69720038T2 (de) * 1996-12-13 2003-08-28 Banyu Pharmaceutical Co., Ltd. Aminopyrazolderivate
FR2758328B1 (fr) * 1997-01-15 1999-04-02 Pf Medicament Nouvelles amines aromatiques derivees d'amines cycliques utiles comme medicaments
ATE253111T1 (de) * 1997-08-20 2003-11-15 Univ California Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
EP0943683A1 (en) * 1998-03-10 1999-09-22 Smithkline Beecham Plc Human vanilloid receptor homologue Vanilrep1
CA2334677A1 (en) 1998-06-19 1999-12-23 Vincent Patrick Rocco Preparation of heteroaryl compounds
ES2151828B1 (es) * 1998-07-10 2001-08-16 Esteve Labor Dr Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor.
PL346795A1 (en) 1998-09-22 2002-02-25 Yamanouchi Pharma Co Ltd Cyanophenyl derivatives
SE9803773D0 (sv) 1998-11-05 1998-11-05 Astra Pharma Prod Compounds
DE69907963T2 (de) 1998-12-23 2004-05-19 Eli Lilly And Co., Indianapolis Heteroaromatische amide als inhibitoren von faktor xa
EP1146790A4 (en) 1999-01-25 2004-03-17 Smithkline Beecham Corp COMPOUNDS AND METHODS
GB9907097D0 (en) * 1999-03-26 1999-05-19 Novartis Ag Organic compounds
AU4797400A (en) * 1999-05-17 2000-12-05 Eli Lilly And Company Metabotropic glutamate receptor antagonists
WO2001017965A2 (en) * 1999-09-07 2001-03-15 Syngenta Participations Ag Cyanopiperidines as pesticides
EP1272187B1 (de) 2000-03-27 2008-07-30 Abbott GmbH & Co. KG Dopamin-d3-rezeptor-liganden zur behandlung von sucht
AU2001252596A1 (en) * 2000-04-28 2001-11-12 Takeda Chemical Industries Ltd. Melanin concentrating hormone antagonists
PL360495A1 (en) 2000-05-22 2004-09-06 Aventis Pharmaceuticals Inc. Arylmethylamine derivatives for use as tryptase inhibitors
YU96502A (sh) * 2000-06-21 2006-01-16 F. Hoffmann-La Roche Ag. Derivati benzotiazola
EP1313477A4 (en) 2000-07-15 2004-03-03 Smithkline Beecham Corp COMPILATIONS AND METHODS
WO2002008221A2 (en) 2000-07-20 2002-01-31 Neurogen Corporation Capsaicin receptor ligands
EP1437344A4 (en) * 2001-09-28 2006-09-20 Takeda Pharmaceutical BENZENE DERIVATIVES AND PROCESS FOR THE PREPARATION AND USE THEREOF
AU2002360621B2 (en) * 2001-12-19 2007-01-25 Merck & Co., Inc. heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
US7390813B1 (en) * 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
JP4583760B2 (ja) * 2002-02-01 2010-11-17 ユーロ−セルティーク エス．エイ． 疼痛の治療に有用な治療薬
AU2003245773A1 (en) 2002-02-15 2003-09-04 Glaxo Group Limited Vanilloid receptor modulators
US6974818B2 (en) * 2002-03-01 2005-12-13 Euro-Celtique S.A. 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
GB0209715D0 (en) * 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US20030232836A1 (en) * 2002-05-23 2003-12-18 Stewart Andrew O. Acetamides and benzamides that are useful in treating sexual dysfunction
WO2003099266A2 (en) * 2002-05-23 2003-12-04 Abbott Laboratories Acetamides and benzamides that are useful in treating sexual dysfunction
ES2464157T3 (es) 2002-06-26 2014-05-30 Ono Pharmaceutical Co., Ltd. Remedios para enfermedades causadas por contracción o dilatación vascular
JP4621502B2 (ja) * 2002-06-28 2011-01-26 ユーロ−セルティーク エス．エイ． 疼痛の治療に有用な治療剤
US7262194B2 (en) * 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7157462B2 (en) * 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
DE10252666A1 (de) * 2002-11-11 2004-08-05 Grünenthal GmbH N-Piperidyl-cyclohexan-Derivate
US7582635B2 (en) * 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
WO2004080411A2 (en) * 2003-03-07 2004-09-23 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
DE10311065A1 (de) * 2003-03-13 2004-09-23 Abbott Gmbh & Co. Kg Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
US20060217371A1 (en) 2003-04-28 2006-09-28 Olivier Bezencon Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors
JP5279987B2 (ja) * 2003-05-20 2013-09-04 味の素株式会社 アミド誘導体
AR044688A1 (es) * 2003-06-12 2005-09-21 Euro Celtique Sa Agentes terapeuticos utiles para el tratamiento del dolor
US7129235B2 (en) * 2003-07-11 2006-10-31 Abbott Laboratories Amides useful for treating pain
US20050009841A1 (en) * 2003-07-11 2005-01-13 Zheng Guo Zhu Novel amides useful for treating pain
ATE430741T1 (de) * 2003-07-24 2009-05-15 Euro Celtique Sa Piperidinverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
CA2533515C (en) 2003-07-24 2011-05-31 Euro-Celtique S.A. Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
CA2533898A1 (en) * 2003-07-29 2005-02-10 Xenon Pharmaceuticals Inc. Pyridyl derivatives and their use as therapeutic agents
US7456180B2 (en) * 2003-07-30 2008-11-25 Xenon Pharmaceuticals Inc. Piperazine derivatives and their use as therapeutic agents
WO2005011653A2 (en) * 2003-07-30 2005-02-10 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
ATE524455T1 (de) 2003-08-01 2011-09-15 Euro Celtique Sa Therapeutische mittel zur schmerzbehandlung
SI2017276T1 (sl) * 2003-09-22 2011-05-31 Euro Celtique Sa Fenil-karboksamidne spojine, uporabne za tretiranje bolečine
EP1680431A1 (en) * 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
EP1684694A2 (en) * 2003-11-21 2006-08-02 Array Biopharma, Inc. Akt protein kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2006528643A5 (enExample)
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2009526868A5 (enExample)
JP2004501940A5 (enExample)
JP2004182741A5 (enExample)
JP2005523922A5 (enExample)
JP2005526076A5 (enExample)
RU2014107430A (ru) Моногидрат мезилата n-[5-(аминосульфонил)-4-метил-1,3-тиазол-2-ил]-n-метил-2-[4-(2-пиридинил)фенил]ацетамида
JP2004521124A5 (enExample)
JP2011520815A5 (enExample)
JP2013504593A5 (enExample)
JP2004517813A5 (enExample)
JP2006514114A5 (enExample)
JP2010510976A5 (enExample)
JP2008504265A5 (enExample)
JP2009508811A5 (enExample)
JP2008511601A5 (enExample)
JP2010090149A5 (enExample)
JP2009501198A5 (enExample)
JP2005526836A5 (enExample)
JP2008536833A5 (enExample)
JP2014515349A5 (enExample)
JP2005535731A5 (enExample)
JP2007502817A5 (enExample)
JP2005525392A5 (enExample)